The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase activation by nuclear factor-κB

Spink, J., Cohen, J. and Evans, T. J. (1995) The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase activation by nuclear factor-κB. Journal of Biological Chemistry, 270(49), pp. 29541-29547. (doi: 10.1074/jbc.270.49.29541)

Full text not currently available from Enlighten.


The production of inducible nitric oxide synthase (iNOS) within vascular smooth muscle (VSM) cells following exposure to proinflammatory cytokines is a major cause of the vasorelaxation and hypotension of septic shock. We have defined the cytokine-responsive element of the murine iNOS promoter, transfected into a VSM cell line, and the role of the NF-κB/Rel family of proteins in iNOS gene activation in these cells. The combination of interleukin-1, interferon-Graphic, and tumor necrosis factor-α stimulates promoter activity by a factor of 8.1-fold; single cytokines show little activity, while pairs of cytokines produce an intermediate effect. Using a series of promoter deletion mutants, we have defined the cytokine-responsive element from position −890 to −1002; this region contains an NF-κB-binding site as well as a number of interferon response elements. Nuclear proteins from cytokine-stimulated VSM cells which bind to an oligonucleotide containing this κB site are composed of p65 together with an unidentified protein of 50 kDa, which is not a known Rel family member. A promoter mutant with a 2-base pair change within this κB site, which abolishes NF-κB binding, has an activity of only approximately 34% (S.E. ± 1.5) of the wild-type promoter. In addition, protein binding to this site is abolished by a specific inhibitor of NF-κB activation, which also abrogates iNOS activity. Residual inducibility in such mutant promoters is attributable to the presence of an independently functioning downstream κB site (−85 to −75). The mechanism by which NF-κB activates the iNOS promoter in VSM cells in response to cytokines appears to be markedly different to that operative in macrophages in response to lipopolysaccharide.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Evans, Professor Tom
Authors: Spink, J., Cohen, J., and Evans, T. J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Journal of Biological Chemistry
Publisher:American Society for Biochemistry and Molecular Biology, Inc.
ISSN (Online):1083-351X

University Staff: Request a correction | Enlighten Editors: Update this record